Principles of Reporting. 1.1 The presentation of results of operations of the Parties will include each of the following line items (as each is defined in Exhibit B or elsewhere in the Agreement) be based on each Party’s respective financial information presented separately and on a consolidated basis in the reporting format depicted as follows (the “P&L”): [***] [***] [***] [***]
Appears in 2 contracts
Samples: Mrna Cancer Vaccine Collaboration and License Agreement, Mrna Cancer Vaccine Collaboration and License Agreement
Principles of Reporting. 1.1 The presentation of results of operations operation of the Parties with respect to Co-Co Products for U.S. Administration will include each of the following line items (as each is defined in Exhibit B or elsewhere in the Agreement) be based on each Party’s respective financial information presented separately and on a consolidated basis in the reporting format depicted as follows (the “P&L”): follows: [***] [***] [***] [***] [***] [***]
Appears in 2 contracts
Samples: Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.), Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.)
Principles of Reporting. 1.1 The presentation of results of operations of the Parties will include each of the following line items (as each is defined in Exhibit B or elsewhere in the Agreement) be based on each Party’s respective financial information presented separately and on a consolidated basis in the reporting format depicted as follows (the “P&L”): [***] [***] [***] [***] [***] [***] [***]
Appears in 2 contracts
Samples: Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.), Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.)
